Home > Products > CD19 & CD64 > Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Fab-scFv-scFv)

Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Fab-scFv-scFv)  (CAT#: TRIB-044)

Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Fab-scFv-scFv) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD19 antibody are both extended with the scFv fragment from an anti-CD64 antibody. This BsAb can retarget neutrophils to tumor cells. It is designed for the research of B cell lymphoma; Leukemia therapy.
Datasheet INQUIRY

Specifications

Targets
CD19 & CD64
Type
Fab-scFv-scFv
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma; Leukemia
Host Animal 1
Mouse
Host Animal 2
Mouse

Targets

Target 1
CD19
Gene ID
UniProt ID
Alternative Names
CD19; CD19 molecule; Cluster of differentiation 19; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4
Target 2
CD64
Gene ID
UniProt ID
Alternative Names
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD19 & CD64"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Fab-scFv-scFv) (TRIB-044). Click the button below to contact us or submit your feedback about this product.